Nuwellis Inc reports results for the quarter ended September 30 - Earnings Summary

• Nuwellis Inc NUWE.OQ reported quarterly adjusted earnings of $1.74​​ per share for the quarter ended September 30, higher than the same quarter last year, when the company reported EPS of $-63.35. The mean expectation of two analysts for the quarter was for a loss of $1.28 per share. Wall Street expected results to range from $-1.68 to -88 cents per share.

• Revenue fell 1.9% to $2.37 million from a year ago; analysts expected $2.36 million.

• Nuwellis Inc's reported EPS for the quarter was $1.74​.

• The company reported quarterly net income of $2.54 million.

• Nuwellis Inc shares had risen by 52.1% this quarter and lost 91.1% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 33% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."

• The average consensus recommendation for the advanced medical equipment & technology peer group is "hold."

Wall Street's median 12-month price target for Nuwellis Inc is $16.00

This summary was machine generated from LSEG data November 11 at 03:30 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)